LAURA KIELY: Open Payments
NPI 1063831899 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 25 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,965 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 6 | $162 |
| UCB, Inc. | 2 | $74 |
| Amgen Inc. | 3 | $74 |
| ABBVIE INC. | 2 | $58 |
| Smith+Nephew, Inc. | 2 | $45 |
| Biofrontera Inc. | 2 | $42 |
| Organon LLC | 1 | $32 |
| Surgenex LLC | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| MERZ NORTH AMERICA, INC. | 1 | $20 |
Products named: NOVACHOR, Bimzelx, OTEZLA, CYGNUS DUAL, RINVOQ, SurGraft, SKYRIZI, OASIS.
Industry payments across FL — which companies pay providers there.
